CIK 0000872589 · Large accelerated filer
REGENERON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- REGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NY
- Entity type
- operating
- EIN
- 133444607
- Phone
- 9148477000
- Business address
- 777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, 10591
- Former names
- REGENERON PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $51,901,544
- in 11 filings, $8.6M under 10b5-1 plans
Net −$51,901,544. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-01 | RYAN ARTHUR F Director | Sale 10b5-1 | −6 | $817.52 | $5K | 18,491 |
| 2023-12-01 | RYAN ARTHUR F Director | Sale 10b5-1 | −2 | $818.76 | $2K | 18,489 |
| 2023-12-01 | RYAN ARTHUR F Director | Sale 10b5-1 | −7 | $819.62 | $6K | 18,482 |
| 2023-12-01 | RYAN ARTHUR F Director | Sale 10b5-1 | −9 | $820.50 | $7K | 18,473 |
| 2023-12-01 | RYAN ARTHUR F Director | Sale 10b5-1 | −2 | $821.92 | $2K | 18,471 |
| 2023-12-01 | RYAN ARTHUR F Director | Sale 10b5-1 | −1 | $822.49 | $822 | 18,470 |
| 2023-12-01 | RYAN ARTHUR F Director | Sale 10b5-1 | −6 | $823.36 | $5K | 18,464 |
| 2023-12-01 | RYAN ARTHUR F Director | Sale 10b5-1 | −3 | $824.66 | $2K | 18,461 |
| 2023-12-01 | RYAN ARTHUR F Director | Sale 10b5-1 | −2 | $825.38 | $2K | 18,459 |
| 2023-12-01 | RYAN ARTHUR F Director | Sale 10b5-1 | −10 | $826.62 | $8K | 18,449 |
| 2023-12-01 | RYAN ARTHUR F Director | Sale 10b5-1 | −2 | $827.61 | $2K | 18,447 |
| 2023-11-14 | MURPHY ANDREW J EVP Research | Sale 10b5-1 | −752 | $794.57 | $598K | 65,161 |
| 2023-11-14 | MURPHY ANDREW J EVP Research | Sale 10b5-1 | −347 | $795.38 | $276K | 64,814 |
| 2023-11-14 | MURPHY ANDREW J EVP Research | Sale 10b5-1 | −204 | $797.79 | $163K | 64,610 |
| 2023-11-14 | MURPHY ANDREW J EVP Research | Sale 10b5-1 | −1,614 | $798.63 | $1.3M | 62,996 |
| 2023-11-14 | MURPHY ANDREW J EVP Research | Sale 10b5-1 | −1,601 | $799.48 | $1.3M | 61,395 |
| 2023-11-14 | MURPHY ANDREW J EVP Research | Sale 10b5-1 | −382 | $800.55 | $306K | 61,013 |
| 2023-11-14 | MURPHY ANDREW J EVP Research | Sale 10b5-1 | −877 | $801.56 | $703K | 60,136 |
| 2023-11-14 | MURPHY ANDREW J EVP Research | Sale 10b5-1 | −347 | $802.63 | $279K | 59,789 |
| 2023-11-14 | MURPHY ANDREW J EVP Research | Sale 10b5-1 | −330 | $803.38 | $265K | 59,459 |
Page 47 of 49 · 971 trades